Differential expression of Bcl-2 and Bcl-xL in human small cell lung cancer (SCLC) and adenocarcinoma of the lung (ACL)

被引:0
作者
Li, E
Xiao, H
Vikram, B
机构
[1] NYU Med Ctr, New York, NY 10016 USA
[2] Montefiore Med Ctr, Bronx, NY 10467 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1314
引用
收藏
页码:223A / 223A
页数:1
相关论文
共 50 条
  • [31] Expression of bcl-2, bax and bcl-xl in human gliomas:: A re-appraisal
    Martin, S
    Toquet, C
    Oliver, L
    Cartron, PF
    Perrin, P
    Meflah, K
    Cuillère, P
    Vallette, FM
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2001, 52 (02) : 129 - 139
  • [32] A phase I study of novel dual Bcl-2/Bcl-xL inhibitor APG-1252 in patients with advanced small cell lung cancer (SCLC) or other solid tumor.
    Lakhani, Nehal J.
    Rasco, Drew W.
    Tolcher, Anthony W.
    Huang, Yingjie
    Ji, Jiao
    Wang, Hengbang
    Dong, Qi
    Men, Lichuang
    O'Rourke, Timothy J.
    Chandana, Sreenivasa R.
    Amaya, Alex
    Cole, Yvette
    Kaiser, Brianne
    Mays, Theresa A.
    Patnaik, Amita
    Papadopoulos, Kyriakos P.
    Yang, Dajun
    Zhai, Yifan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Combined BCL-2/XL and mTor inhibition promotes apoptosis in small cell lung cancer
    Gao, Li
    Barnwell, Brittany
    Kalvala, Arjun
    Otterson, Gregory A.
    Duan, Wenrui
    Villalona-Calero, Miguel A.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [34] Subcellular distribution and function of Bcl-2 and Bcl-xL in the beta cell
    Luciani, D. S.
    Widenmaier, S.
    Yeung, J.
    McIntosh, C.
    Johnson, J. D.
    [J]. DIABETOLOGIA, 2008, 51 : S218 - S219
  • [35] Heterodimerization of Bcl-2 and BcL-XL with Bax and Bad in colorectal cancer
    Hattori, T
    Ookawa, N
    Fujita, R
    Fukuchi, K
    [J]. ACTA ONCOLOGICA, 2000, 39 (04) : 495 - 500
  • [36] Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells
    Lei, Xiaoyong
    Huang, Zexiang
    Zhong, Miao
    Zhu, Bingyang
    Tang, Shengsong
    Liao, Duanfang
    [J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2007, 39 (05) : 344 - 350
  • [37] Bcl-2 and Bcl-xL mediate resistance to receptor tyrosine kinase-targeted therapy in lung and gastric cancer
    Jin, Junfei
    Xiong, Ying
    Cen, Bo
    [J]. ANTI-CANCER DRUGS, 2017, 28 (10) : 1141 - 1149
  • [38] Differential expression of antiapoptotic genes in human endometrial carcinoma:: bcl-XL succeeds bcl-2 function in neoplastic cells
    Crescenzi, E
    Criniti, V
    Pianese, M
    Tecce, MF
    Palumbo, G
    [J]. GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 419 - 428
  • [39] Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists
    Wang, SM
    Yang, DJ
    Lippman, ME
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (05) : 133 - 142
  • [40] Esophageal squamous cell carcinomas and expression of p53, Bcl-2, and Bcl-XL
    Vlachos, Konstantinos
    Siafakas, Nikolaos
    Karameris, Andreas
    Theodoropoulos, George
    Parassi, Ekaterini
    Peros, George
    Papadopoulos, Jordan
    Hakim, Nadey
    [J]. INTERNATIONAL SURGERY, 2008, 93 (02) : 63 - 71